ALCEX | DOXGX | ALCEX / DOXGX | |
Total Expense Ratio | 0.00 | 0.41 | - |
Annual Report Gross Expense Ratio | 0.15 | 0.46 | 33% |
Fund Existence | 3 years | 3 years | - |
Gain YTD | -2.680 | 1.241 | -216% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 402M | 110B | 0% |
Annual Yield % from dividends | 1.88 | 1.54 | 122% |
Returns for 1 year | 5.34 | 3.21 | 166% |
Returns for 3 years | N/A | 18.23 | - |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYHEX | 103.65 | -0.22 | -0.21% |
Rydex Health Care A | |||
ITCSX | 28.75 | -0.10 | -0.35% |
VY® T. Rowe Price Capital Apprec S | |||
CILGX | 14.94 | -0.08 | -0.53% |
Clarkston Institutional | |||
GGEZX | 25.79 | -0.24 | -0.92% |
GuideStone Funds Growth Equity Investor | |||
JFAIX | 35.47 | -0.49 | -1.36% |
JHancock Fundamental All Cap Core R6 |